1Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation, 2010,121 : e46-e215.
2Mancia G, Laurent S, Agabiti Rosei E, et al. Reappraisal of Eu ropean guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens, 2009,27:2121- 2158.
3Ouinn RR, Hemmelgarn BR,Padwal RS,et al. The 2010 Cana dian Hypertension Education Program recommendations for the management of hypertension: part I blood pressure meas urement, diagnosis and assessment of risk. Can J Cardiol, 2010, 26 : 241-248.
5Verdecchia P, Staessen JA, Angeli F, et al. Usual versus tight control of systolic blood pressure in nondiabetic patients with hypertension(Cardio-Sis) :an open label randomised trial. Lan cet,2009,374:525- 533.
6Cushman WC, Evans GW, Byington RP,et al. Effects of inten sive blood-pressure contro1. in type 2 diabetes raellitus. N Engl:1 Med, 2010,362 : 1575-1585.
7Low PA. Prevalence of orthostatie bypotension. Clin Auton Res, 2008,18 : 8-13.
8Erne P, Allemann Y. Comments to the 2007 recommendations for the treatment of essential hypertension by the Swiss Socie- ty of Hypertension. Kardiovaskul:ire Medizin, 2008,11 : 26- 28.
9Jamerson K,Weber MA, Bakris GL, et al. Benazepril plus am- lodipine or hyclrochlorothiazide for hypertension in high risk patients. N Engl J Med, 2008,359 : 2417- 2428.
